Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Stanford team develops effective method for topical genetic immunization

Sep. 2, 1999

Medarex and Gilead enter agreement concerning anti-CTLA-4 rights

Sep. 2, 1999

SciClone licenses new class of immunomodulators from University of California

Aug. 31, 1999

General Hospital Corp. discloses DNA vaccine for preventing, treating hepatitis C

Aug. 27, 1999

Nabi reports positive interim results from Nabi-StaphVAX pivotal trial

Aug. 27, 1999

Retrospective study supports safety of xenotransplantation

Aug. 25, 1999

Phase I study of Avant's vaccine delivery system shows promising results

Aug. 24, 1999

Dynavax completes patient enrollment and dosing in phase I ragweed allergy trial

Aug. 24, 1999

Xoma and Genentech expand hu1124 collaboration to include transplantation

Aug. 23, 1999

Known anti-HIV compound also shows potential in treating immune disorders

Aug. 20, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...